Market challenges have been well documented and mostly negotiated thus far by Epwin. Management has elected to take action to reduce costs and capacity in the light of ongoing market conditions. We expect more detail with the release of H117 results on 13 September. Epwin remains in robust financial health and in our view, is in a position to sustain its dividend – currently yielding c 10%.

Continue reading

This version is programmatically created by Responsive Labs and qualified in its entirety to the original PDF.

Powered by Responsive Labs